Overview

A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This is a multicenter extension trial in adult hypogonadal males. The purpose of this study is to evaluate the safety of testosterone gel delivered using an applicator over an extended period of time.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate